These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11347971)

  • 1. A1 adenosine receptors and their ligands: overview and recent developments.
    Müller CE
    Farmaco; 2001; 56(1-2):77-80. PubMed ID: 11347971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
    Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
    J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
    Alnouri MW; Jepards S; Casari A; Schiedel AC; Hinz S; Müller CE
    Purinergic Signal; 2015 Sep; 11(3):389-407. PubMed ID: 26126429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicinal chemistry of adenosine A3 receptor ligands.
    Müller CE
    Curr Top Med Chem; 2003; 3(4):445-62. PubMed ID: 12570761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives.
    Deb PK; Deka S; Borah P; Abed SN; Klotz KN
    Curr Pharm Des; 2019; 25(25):2697-2715. PubMed ID: 31333094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal chemistry of adenosine, P2Y and P2X receptors.
    Jacobson KA; Müller CE
    Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted 4-phenylthiazoles: Development of potent and selective A
    Abdelrahman A; Yerande SG; Namasivayam V; Klapschinski TA; Alnouri MW; El-Tayeb A; Müller CE
    Eur J Med Chem; 2020 Jan; 186():111879. PubMed ID: 31780082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms.
    Schiedel AC; Lacher SK; Linnemann C; Knolle PA; Müller CE
    Purinergic Signal; 2013 Sep; 9(3):351-65. PubMed ID: 23359122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine receptor ligands-recent developments part I. Agonists.
    Muller CE
    Curr Med Chem; 2000 Dec; 7(12):1269-88. PubMed ID: 11032971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine receptors and their ligands.
    Klotz KN
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):382-91. PubMed ID: 11111832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors.
    Ozola V; Thorand M; Diekmann M; Qurishi R; Schumacher B; Jacobson KA; Müller CE
    Bioorg Med Chem; 2003 Feb; 11(3):347-56. PubMed ID: 12517430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to adenosine receptors as therapeutic targets.
    Jacobson KA
    Handb Exp Pharmacol; 2009; (193):1-24. PubMed ID: 19639277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New substituted 9-alkylpurines as adenosine receptor ligands.
    Camaioni E; Costanzi S; Vittori S; Volpini R; Klotz KN; Cristalli G
    Bioorg Med Chem; 1998 May; 6(5):523-33. PubMed ID: 9629466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicinal chemistry of adenosine A1 receptor ligands.
    Soudijn W; van Wijngaarden I; IJzerman AP
    Curr Top Med Chem; 2003; 3(4):355-67. PubMed ID: 12570755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the adenosine receptors mediating hypothermia in the conscious mouse.
    Anderson R; Sheehan MJ; Strong P
    Br J Pharmacol; 1994 Dec; 113(4):1386-90. PubMed ID: 7889296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in adenosine receptor ligands and their potential as novel drugs.
    Müller CE; Jacobson KA
    Biochim Biophys Acta; 2011 May; 1808(5):1290-308. PubMed ID: 21185259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Amino[1,2,4]triazolo[1,5-c]quinazolines and Derived Novel Heterocycles: Syntheses and Structure-Activity Relationships of Potent Adenosine Receptor Antagonists.
    Burbiel JC; Ghattas W; Küppers P; Köse M; Lacher S; Herzner AM; Kombu RS; Akkinepally RR; Hockemeyer J; Müller CE
    ChemMedChem; 2016 Oct; 11(20):2272-2286. PubMed ID: 27531666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
    Abbracchio MP; Cattabeni F
    Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine receptor-mediated coronary vascular protection in post-ischemic mouse heart.
    Zatta AJ; Matherne GP; Headrick JP
    Life Sci; 2006 Apr; 78(21):2426-37. PubMed ID: 16300799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Aryladenine Derivatives as a Potent Scaffold for Adenosine Receptor Antagonists: The 6-Morpholino Derivatives.
    Areias F; Correia C; Rocha A; Teixeira S; Castro M; Brea J; Hu H; Carlsson J; Loza MI; Proença MF; Carvalho MA
    Molecules; 2024 May; 29(11):. PubMed ID: 38893418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.